This month’s “Company Spotlight” takes a closer look at Deepcell, a company that is building a platform for the identification, isolation, and classification of viable cells based on their morphological distinctions for...read more
Category - Drug discovery
We Invite you to join enlightenbio’s Subject Matter Expert Network!
enlightenbio is a boutique consultancy providing product strategy and market intelligence to precision medicine industries. Our mission is to help our clients successfully develop, launch, and market exceptional...read more
Genomenon Raises $20M Series B Financing, Launching a New Era in AI-Powered Genomic Data
Financing led by Beringea and Spring Mountain Capital to fuel continued growth in pharmaceutical and clinical diagnostic markets Genomenon®Inc., an AI-driven genomics company, today announced the completion of a...read more
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
Company is pioneering true “search and replace” gene editing to address the fundamental genetic causes of disease, restore normal gene function, and potentially provide patients with long-lasting cures Company led by...read more
